Virus-Like Particles Market Is Expected To See Huge Growth. Latest Research Report, Forecast 2028

1
Virus-Like Particles Market Global Analysis and
Forecast to 2028

• Published Date Nov 2021

Email sales_at_theinsightpartners.com
2
Report Studies
Email sales_at_theinsightpartners.com

• Virus-Like Particles Market Forecast to 2028 -
  COVID-19 Impact and Global Analysis By Product
  Type (Hepatitis, Cancer, Others) Source (Yeast,
  Insect cells, Others) Application (Vaccine, and
  Therapeutics and Imaging Agents)

3
Virus-Like Particles Market Overview
Email sales_at_theinsightpartners.com

• The virus-like particles (VLPs) market is
  projected to reach US 7,858.82 million by 2028
  from US 4,601.84 million in 2021 it is expected
  to grow at a CAGR of 7.9 from 2021 to 2028.
• The commercialization of virus-like particles
  -based vaccines against human and animal viruses,
  vigorous research and development activities for
  the development of virus-like particles -based
  viral vaccines, and virus-like particles emerging
  as a reliable immunotherapy platform for allergic
  diseases are the key driving factors responsible
  for the overall market growth. However, technical
  challenges related to the design, purification,
  and storage of eVLPs impede the overall market
  growth. Additionally, complexities associated
  with the manufacturing of virus-like particles
  vaccines, coupled with excess cost and time
  requirement of processes (such as downstream
  processing for virus-like particles -based
  vaccines), further limit the global market
  growth.

4
Key Segment Market
Email sales_at_theinsightpartners.com

• Segment By Type-
• By Product Type (Hepatitis, Cancer, Others)
• Application (Vaccine, and Therapeutics and
  Imaging Agents)
• Source (Yeast, Insect cells, Others)

Download Sample Here
5
Virus-Like Particles Market Value
Email sales_at_theinsightpartners.com

• CAGR of 7.9
• (2021 - 2028)

Download Sample
6
Company Profiles
Email sales_at_theinsightpartners.com

• Merck Co., Inc.
• GlaxoSmithKline plc.
• Pfizer Inc.
• Dynavax Technologies
• Sanofi
• Wantai BioPharm
• Serum Institute of India Pvt. Ltd.
• BHARAT BIOTECH
• LG Chem
• VBI Vaccines Inc.

Download Sample Here
7
By Geography
Email sales_at_theinsightpartners.com

• North America (the US, Canada, and Mexico)
• Europe (the UK, Germany, France, Italy, Spain,
  and the Rest of Europe)
• Asia Pacific (China, Japan, India, Australia,
  South Korea, and the Rest of Asia Pacific)
• Middle East Africa (the UAE, Saudi Arabia,
  South Africa, and the Rest of Middle East
  Africa)
• South Central America (Brazil, Argentina, and
  the Rest of South Central America).

8
THANKYOU!

• Phone  [phone]

• E-Mail sales_at_theinsightpartners.com